Particle size and activation threshold: a new dimension of danger signaling.
Rettig
Lorna
L
Department of Oncology, University Hospital of Zürich, Zürich, Switzerland.
Haen
Sebastian P
SP
Bittermann
Anne Greet
AG
von Boehmer
Lotta
L
Curioni
Alessandra
A
Krämer
Stefanie D
SD
Knuth
Alexander
A
Pascolo
Steve
S
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology; D000818:Animals; D001483:Base Sequence; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D066298:In Vitro Techniques; D016898:Interferon-alpha / Q000096:biosynthesis; D008562:Membrane Glycoproteins / Q000172:deficiency / Q000235:genetics / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D053758:Nanoparticles / Q000737:chemistry; D009838:Oligodeoxyribonucleotides / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000494:pharmacology; D010316:Particle Size; D010587:Phagocytosis; D011479:Protamines / Q000737:chemistry / Q000276:immunology; D012313:RNA / Q000737:chemistry* / Q000235:genetics / Q000276:immunology* / Q000494:pharmacology; D020871:RNA Stability; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology*; D051199:Toll-Like Receptor 7 / Q000172:deficiency / Q000235:genetics / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D016898:Interferon-alpha; D008562:Membrane Glycoproteins; D009838:Oligodeoxyribonucleotides; D011479:Protamines; C477038:Tlr7 protein, mouse; D051199:Toll-Like Receptor 7; D014409:Tumor Necrosis Factor-alpha; D012313:RNA